Analysis of Gut Microbiota and Their Metabolic Potential in Patients with Schizophrenia Treated with Olanzapine: Results from a Six-Week Observational Prospective Cohort Study

The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice

(2019) Peng Zheng et al.   Science Advances

Adjunctive nutrients in first-episode psychosis: A systematic review of efficacy, tolerability and neurobiological mechanisms

(2018) Joseph Firth et al.   Early Intervention in Psychiatry

Ketogenic diet for schizophrenia: Nutritional approach to antipsychotic treatment

(2018) Adam Włodarczyk et al.   MEDICAL HYPOTHESES

Early prediction of olanzapine-induced weight gain for schizophrenia patients

(2018) Ching-Hua Lin et al.   PSYCHIATRY RESEARCH

Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations

(2018) Norbert Müller   SCHIZOPHRENIA BULLETIN

The role of the gut microbiome in systemic inflammatory disease

(2018) Jose C Clemente et al.   BMJ-British Medical Journal

The role of the gut microbiome in systemic inflammatory disease

(2018) Jose C Clemente et al.   BMJ-British Medical Journal

Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota

(2018) Amy Chia-Ching Kao et al.   Translational Psychiatry

Profiling of Amino Acids and Their Derivatives Biogenic Amines Before and After Antipsychotic Treatment in First-Episode Psychosis

(2018) Liisa Leppik et al.   Frontiers in Psychiatry

Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study

(2018) Yang Shen et al.   SCHIZOPHRENIA RESEARCH

Coenzyme Q10 and neuropsychiatric and neurological disorders: relevance for schizophrenia

(2018) Áine Maguire et al.   NUTRITIONAL NEUROSCIENCE

Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome

(2018) Karolina Skonieczna-Żydecka et al.   PSYCHOPHARMACOLOGY

The Emerging Role of Altered d-Aspartate Metabolism in Schizophrenia: New Insights From Preclinical Models and Human Studies

(2018) Francesco Errico et al.   Frontiers in Psychiatry

Recovery of gut microbiota of healthy adults following antibiotic exposure

(2018) Albert Palleja et al.   Nature Microbiology

International trends in antipsychotic use: A study in 16 countries, 2005–2014

(2017) Óskar Hálfdánarson et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort

(2017) Stephanie A. Flowers et al.   PHARMACOTHERAPY

From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases

(2017) Wojciech Marlicz et al.   Expert Review of Gastroenterology & Hepatology

Serum fatty acid patterns in patients with schizophrenia: a targeted metabonomics study

(2017) X Yang et al.   Translational Psychiatry

Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain

(2017) T D Purves-Tyson et al.   Translational Psychiatry

Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response

(2017) Emanuel Schwarz et al.   SCHIZOPHRENIA RESEARCH

Complex heatmaps reveal patterns and correlations in multidimensional genomic data

(2016) Zuguang Gu et al.   BIOINFORMATICS

Adjunctive Taurine in First-Episode Psychosis

(2016) Colin P. O’Donnell et al.   JOURNAL OF CLINICAL PSYCHIATRY

From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways

(2016) G B Rogers et al.   MOLECULAR PSYCHIATRY

Lower folate levels in schizophrenia: A meta-analysis

(2016) Bing Cao et al.   PSYCHIATRY RESEARCH

Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis

(2016) Davy Vancampfort et al.   World Psychiatry

Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics

(2016) Britta Galling et al.   JAMA Psychiatry

From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids Metabolism

(2016) Rolando I. Castillo et al.   Frontiers in Neuroscience

VSEARCH: a versatile open source tool for metagenomics

(2016) Torbjørn Rognes et al.   PeerJ

Severe disturbance of glucose metabolism in peripheral blood mononuclear cells of schizophrenia patients: a targeted metabolomic study

(2015) Mei-Ling Liu et al.   Journal of Translational Medicine

Use of the second-generation antipsychotic, risperidone and secondary weight gain are associated with an altered gut microbiota in children

(2015) S M Bahr et al.   Translational Psychiatry

Composition, taxonomy and functional diversity of the oropharynx microbiome in individuals with schizophrenia and controls

(2015) Eduardo Castro-Nallar et al.   PeerJ

Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis

(2014) Matti Penttilä et al.   BRITISH JOURNAL OF PSYCHIATRY

Do antipsychotics increase diabetes risk in children and adolescents?

(2014) Britta Galling et al.   Expert Opinion On Drug Safety

Weight gain and antipsychotics: a drug safety review

(2014) Richard Musil et al.   Expert Opinion On Drug Safety

Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis

(2014) Maarten Bak et al.   PLoS One

The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in Mouse

(2014) Andrew P. Morgan et al.   PLoS One

Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors

(2013) Rocio Pérez-Iglesias et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences

(2013) Morgan G I Langille et al.   NATURE BIOTECHNOLOGY

phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data

(2013) Paul J. McMurdie et al.   PLoS One

Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat

(2013) K J Davey et al.   Translational Psychiatry

Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia

(2012) Jian-Jun Ou et al.   PSYCHOPHARMACOLOGY

Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters

(2012) Kieran J. Davey et al.   PSYCHOPHARMACOLOGY

Os efeitos do estresse na função do eixo hipotalâmico-pituitário-adrenal em indivíduos com esquizofrenia

(2012) Francesca L. Guest et al.   Archives of Clinical Psychiatry

Polyunsaturated Fatty Acid Concentration Predicts Myelin Integrity in Early-Phase Psychosis

(2012) B. D. Peters et al.   SCHIZOPHRENIA BULLETIN

Metabolic Reconstruction for Metagenomic Data and Its Application to the Human Microbiome

(2012) Sahar Abubucker et al.   PLoS Computational Biology

Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia

(2011) Haya Ascher-Svanum et al.   BMC Psychiatry

Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation

(2011) M. De Hert et al.   BRITISH JOURNAL OF PSYCHIATRY

Enterotypes of the human gut microbiome

(2011) Manimozhiyan Arumugam et al.   NATURE

Folate supplementation in schizophrenia: A possible role for MTHFR genotype

(2011) Michele Hill et al.   SCHIZOPHRENIA RESEARCH

Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes

(2011) G. D. Wu et al.   SCIENCE

Metagenomic biomarker discovery and explanation

(2011) Nicola Segata et al.   GENOME BIOLOGY

Identification of LPS-inducible genes downregulated by ubiquinone in human THP-1 monocytes

(2010) Constance Schmelzer et al.   BIOFACTORS

Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients

(2010) P. Bubber et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Plasma alanine levels increase in patients with schizophrenia as their clinical symptoms improve—Results from the Juntendo University Schizophrenia Projects (JUSP)

(2010) Tokiko Hatano et al.   PSYCHIATRY RESEARCH

Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities

(2009) P. D. Schloss et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

(2009) M. De Hert et al.   EUROPEAN PSYCHIATRY

Understanding nutrition, depression and mental illnesses

(2009) TS Sathyanarayana Rao et al.   Indian Journal of Psychiatry

Kynurenine pathway in psychosis: evidence of increased tryptophan degradation

(2008) S Barry et al.   JOURNAL OF PSYCHOPHARMACOLOGY